Evidence map›Paper›PMID 39103200›Full record

ArticleThe British journal of ophthalmology2025

Long-term natural history of ellipsoid zone width in

Michael Heyang, Joshua L Warren, Paulina Ocieczek, Jacque L Duncan, Mariya Moosajee, Lucian V Del Priore, Liangbo Linus Shen

Abstract read
In one paragraph

Article in The British journal of ophthalmology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Michael HeyangDepartment of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, USA.ORCID http://orcid.org/0000-0002-5960-949X
Joshua L WarrenDepartment of Biostatistics, Yale University School of Public Health, New Haven, Connecticut, USA.
Paulina OcieczekMoorfields Eye Hospital NHS Foundation Trust, London, UK.
Jacque L DuncanDepartment of Ophthalmology, University of California San Francisco, San Francisco, California, USA.
Mariya Moosajee *Moorfields Eye Hospital NHS Foundation Trust, London, UK m.moosajee@ucl.ac.uk.ORCID http://orcid.org/0000-0003-1688-5360
Lucian V Del Priore *Department of Ophthalmology and Visual Science, Yale School of Medicine, New Haven, Connecticut, USA.
Liangbo Linus Shen *Department of Ophthalmology, University of California San Francisco, San Francisco, California, USA.ORCID http://orcid.org/0000-0002-1823-0854

Funding

Rapid-Prototyping and Design CoreP30EY002162 · NEI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ULLIAN, ERIK M · 1985 to 2024
$16.8M
NEI NIH HHS P30 EY002162Wellcome Trust
6 · The paper itself

Abstract

aimsTo investigate the long-term natural history of ellipsoid zone (EZ) width in

methodsEZ width measurements from optical coherence tomography were retrospectively obtained from 110 eyes of 55 participants with molecularly confirmed biallelic

resultsCompared with linear and quadratic models, exponential decline best represented the long-term loss of EZ width based on the deviance information criterion score. Log-transformed EZ width declined linearly over 30 years of inferred disease duration (median: 0.063 (IQR: 0.040-0.086) log (µm)/year). Compared with the raw EZ width decline rate, the log-transformed EZ width decline rate required 48% fewer patients to achieve an identically powered 1-year trial (38 vs 73 participants). Log EZ width decline rate was uncoupled from baseline EZ width (Spearman ρ=-0.18, p=0.06) and age (ρ=-0.10, p=0.31). Eyes with Usher syndrome exhibited earlier median onset ages of macular EZ width loss (18.8 (IQR: 13.1-24.7) vs 28.1 (IQR: 18.5-35.8) years, p<0.001) but comparable log EZ width decline rates (0.060 (IQR: 0.035-0.100) vs 0.065 (IQR: 0.050-0.079) log (µm)/year; p=0.42).

conclusionsEZ width follows an exponential decline in

Indexed as

Extracellular Matrix ProteinsRetinaRetinal DiseasesUsher SyndromesAdolescentAdultAgedBayes TheoremDisease ProgressionFemaleFollow-Up StudiesHumansMaleMiddle AgedRetrospective StudiesTomography, Optical CoherenceExtracellular Matrix ProteinsUSH2A protein, humanDegenerationEpidemiologyImagingRetina

Identifiers

PMID39103200
PMCPMC11866300

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.